SG001 Injection

· CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SG001 Injection, covering 2021-11-22 to 2021-11-22. Get the full timeline:

Most recent: Clinical Trial Update: Study of the SG001 Injection for Patients With Relapsed or Metastatic Uterine Cervical Cancer [Phase 2]